AFFY.US Affymax Inc.

Healthcare Biotechnology USA Stocks
0.0008 USD
Close of Nov 12, 2026
0.0007 0.0416
Market cap
USD 30.0K
P/E
-
P/B
0.56x
ROE
225.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2014.

Is AFFY.US undervalued?

Graham number

The Graham number of Affymax Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Affymax Inc. fundamental analysis

No fundamental analysis for Affymax Inc. yet.

Affymax Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Affymax Inc.

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

Full company profile